The Almond-Sized Brain Region That May Run Aging

Key takeaways

• In mice, a single protein in the hypothalamus called Menin declined with age — and removing it in young animals produced thinner skin, lower bone mass, reduced cognitive performance, and a shorter lifespan.
• Restoring Menin in 20-month-old mice improved skin thickness, bone mass, learning, and balance within 30 days.
• The finding suggests aging may be partly coordinated from a small brain region that integrates inflammatory and metabolic signals, rather than only accumulating independently across tissues.
• A related amino acid, D-serine, improved cognition in mice but did not reproduce the body-wide effects — and the human evidence remains very limited.

One protein, several tissues

The hypothalamus is about the size of an almond, and it runs a remarkable amount of the body's background operations: metabolism, temperature, hunger, hormonal signaling. Research over the past decade has increasingly suggested it also has a hand in how the rest of the body ages.

Work led by Lige Leng at Xiamen University, published in PLOS Biology, followed that thread to a specific protein. Menin helps restrain inflammatory signaling in the hypothalamus, and its levels fell with age in particular neurons of the ventromedial hypothalamus — the region involved in metabolic regulation. Notably, the decline was specific to those neurons rather than spread across supporting cells, which argues it reflects a targeted change rather than general wear.

To test whether the decline was a cause or just a companion of aging, the researchers engineered mice in which Menin could be selectively removed. Reducing it in young animals raised hypothalamic inflammation and brought on a cluster of aging traits: lower bone mass, thinner skin, reduced cognitive performance, and a modestly shorter lifespan. Skin and bone are nowhere near the hypothalamus, which is exactly what makes the result interesting.

Running it in reverse

The more striking experiment went the other direction. In 20-month-old mice — elderly, by mouse standards — the team delivered the Menin gene into the hypothalamus so cells there would produce more of the protein.

Thirty days later, the treated animals had thicker skin, greater bone mass, and better performance on tests of learning, cognition, and balance. Lifespan was extended. The improvements were accompanied by higher levels of D-serine in the hippocampus, an amino acid that helps activate receptors involved in adjusting the strength of connections between neurons — the cellular basis of forming a memory.

That gives Menin two apparent routes of influence: damping inflammation, and maintaining the signaling chemistry that supports cognition. The researchers proposed it may be a connecting node between the genetic, inflammatory, and metabolic threads of aging.

Why form matters more than the name

This is where careful reading becomes essential, and where the most useful reader takeaway lives.

A separate, simpler experiment gave mice D-serine in their drinking water for three weeks. Cognitive performance improved, including in older animals. But the broader physical changes — the skin, the bone — did not follow. The supplement reproduced part of the effect, not the system-level one.

There is also a molecular distinction that gets flattened in most coverage. Serine appears in soybeans, eggs, fish, and nuts, but the form built into dietary protein is L-serine. The body can convert L-serine into D-serine, yet the two are not interchangeable, and eating serine-containing foods is not equivalent to the experimental treatment. A 2026 study found that an L-serine-enriched diet did raise blood levels of both forms and partially restored new neuron production in the hippocampus — a real effect, but a different one, measured differently.

And more is not automatically better. A 2025 study in a different model found that an early rise in D-serine accompanied disrupted brain signaling, and that blocking the enzyme producing it reduced later cognitive problems. Same molecule, opposite direction, different biological context.

The human data is thin: one small randomized trial in 50 healthy older adults tested a single dose and found improvement on one computerized task, with no significant benefit across other cognitive or mood measures. That is a starting point, not a finding.

A longevity lens

The durable idea here isn't a molecule. It's that aging may be partly directed rather than purely accumulated.

Supporting work points the same way. A 2024 Cell Metabolism study from Washington University identified a separate group of hypothalamic neurons in communication with fat tissue, where stimulating the system increased physical activity and extended lifespan in mice — a different pathway, same architecture. And when an Allen Institute team profiled roughly 1.2 million mouse brain cells for Nature in 2025, some of the cell types most sensitive to age clustered around the hypothalamus, showing reduced neuronal-function gene activity alongside increased immune-related activity.

Three independent lines of evidence converging on one small region is worth noting. And the recurring pattern in all of them is inflammatory signaling in the brain influencing tissues far from it — which is a reasonable argument for why the unglamorous inputs that lower inflammatory load overall may matter more than any single targeted compound.

The takeaway

This is early-stage mouse work built on a genetic intervention no one is receiving, so the practical implication is conceptual rather than actionable. Read it as a reason to take whole-system thinking seriously: sleep, stress load, movement, and diet quality all feed into the same inflammatory signaling this research places at the center, and they do so through pathways that don't require a lab.

The serine material is the cautionary half. It's a genuinely promising research target and a poor candidate for extrapolation — the form of the molecule, the biological context, and the outcome being measured all change the answer. That's a reasonable filter to apply to any single-compound aging claim, not just this one.

References:

Lige Leng, Ziqi Yuan, Xiao Su, et al. Hypothalamic Menin regulates systemic aging and cognitive decline. PLOS Biology, 2023; 21(3): e3002033. DOI: 10.1371/journal.pbio.3002033

Kelly Jin, Zizhen Yao, Cindy T. J. van Velthoven, et al. Brain-wide cell-type-specific transcriptomic signatures of healthy ageing in mice. Nature, 2025; 638(8049): 182. DOI: 10.1038/s41586-024-08350-8

Kyohei Tokizane, Cynthia S. Brace, Shin-ichiro Imai. DMHPpp1r17 neurons regulate aging and lifespan in mice through hypothalamic-adipose inter-tissue communication. Cell Metabolism, 2024; 36(2): 377. DOI: 10.1016/j.cmet.2023.12.011

J-M. Billard, E. Ploux, S. Largilliere, et al. Early involvement of D-serine in β-amyloid-dependent pathophysiology. Cellular and Molecular Life Sciences, 2025; 82(1). DOI: 10.1007/s00018-025-05691-z

Emmanuel Than-Trong, Lucille Torres, Mylène Gaudin-Guérif, et al. L-serine-enriched diet restores impaired adult neurogenesis in the hippocampus. Journal of Alzheimer's Disease, 2026. DOI: 10.1177/13872877261487394

Marcos Avellar, Linda Scoriels, Caroline Madeira, et al. The effect of D-serine administration on cognition and mood in older adults. Oncotarget, 2016; 7(11): 11881. DOI: 10.18632/oncotarget.7691